CORONA, CA--(Marketwire - March 02, 2009) -
Highlighted Links |
|
Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson’s president and chief executive officer, will provide an overview and update of the Company’s business at the Barclays Capital Global Healthcare Conference on Tuesday, March 10, 2009 at 9:30 a.m. Eastern Daylight Time.
This presentation will be webcast live and can be accessed on Watson Pharmaceuticals’ Investor Relations Web site at http://ir.watson.com. The webcast can also be accessed at the following URL:
http://cc.talkpoint.com/barc002/030909a_rb/?entity=62_WSC1Q3N
An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc. is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes generic and specialty brand pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.
For press releases and other company information, visit Watson Pharmaceuticals’ Web site at http://www.watson.com.
CONTACT:
Watson Pharmaceuticals, Inc.
Patty Eisenhaur
(951) 493-5611